Keywords: Novo Nordisk, US manufacturing facility, Insulin delivery devices

Novo Nordisk to invest $73 million in expanding its US manufacturing facility

Article | 05 October 2010

Print This

Danish insulin giant and diabetes drug major Novo Nordisk (NVO.N) yesterday announced a $73 million expansion of its Clayton, North ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in